BLOOMBERG BUSINESSWEEK: A US company will next month report the results of its study of abiraterone acetate plus prednisone for the treatment of patients with metastatic advanced prostate cancer, also called castration-resistant prostate cancer. READ MORE>
Posts Tagged ‘advanced prostate cancer’
Provenge approval expected to rejuvenate cancer vaccine industry
Posted in Provenge, tagged advanced prostate cancer, cancer research, cancer vaccine industry, catherise, catheter, catheterisation, Dendreon, MARKETWIRE, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, Provenge, Provenge treatment, URO TODAY on September 12, 2010| Leave a Comment »
MARKETWIRE: The approval of Dendreon’s prostate cancer vaccine Provenge in April was a boon for a nascent cancer vaccine industry that had suffered several setbacks, and should lead to an influx of market opportunities and a surge in regulatory activity. READ MORE>
Canadian researchers develop new drug to prolong lives of prostate cancer patients
Posted in Treatment news, tagged advanced prostate cancer, cancer research, catheter, life expectancy, new cancer-fighting drug, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, Vancouver researchers, VANCOUVER SUN on September 1, 2010| Leave a Comment »
VANCOUVER SUN: Vancouver researchers have developed a new cancer-fighting drug that will prolong the life of patients with advanced prostate cancer, doubling their life expectancy compared with a decade ago. READ MORE>
Asthma drug found to prolong life of advanced prostate cancer patients
Posted in Treatment news, tagged advanced prostate cancer, asthma, cancer research, catheter, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, Tranilast, URO TODAY on August 21, 2010| Leave a Comment »
URO TODAY: A drug originally developed to treat asthma, Tranilast, may improve the prognosis of patients with advanced prostate cancer, a Japanese study has shown. READ MORE>
Jury still out on how long immuno-therapeutic drugs like Provenge can prolong life
Posted in Provenge, tagged advanced prostate cancer, cancer research, catheter, immuno-therapy, KANSASCITY.COM, large clinical trials, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, Provenge, Provenge treatment, vaccines on August 21, 2010| Leave a Comment »
KANSASCITY.COM: Researchers can cite anecdotes of cancer patients given months to live who have survived 15 years or longer after receiving vaccines, but so far conclusive evidence from large clinical trials is scant. READ MORE>
ADHD drug helps treat fatigue in men with advanced prostate cancer
Posted in Treatment news, tagged advanced prostate cancer, attention-deficit hyperactivity disorder, blood pressure elevation, cancer research, catheter, fatigue in men with prostate cancer, Methylphenidate, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, URO TODAY on August 15, 2010| Leave a Comment »
URO TODAY: The attention-deficit hyperactivity disorder drug Methylphenidate is effective in treating fatigue in men with prostate cancer,but oncologists need to monitor for possible pulse and blood pressure elevations. READ MORE>
Results soon of phase two trials of new testosterone-lowering drug
Posted in Testosterone treatment, tagged advanced prostate cancer, Bone loss, BUSINESSWIRE, cancer research, castrate level, catheter, comparison of treatments, GTx-758, hot flashes, LHRH analogs, orchiectomy, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate treatment, prostate treatment debate on August 15, 2010| Leave a Comment »
BUSINESSWIRE: The results of phase 2 (there are three) trials of a new drug that reduces testosterone to castrate levels and serum free testosterone to levels lower than orchiectomy or LHRH analogs – without bone loss or hot flashes- are about to be reported in the US. READ MORE>
US doctors reluctant to use proven anti-prostate cancer drug
Posted in Treatment debate, tagged advanced prostate cancer, cancer research, catheter, finasteride, LA TIMES, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer screening, prostate treatment, prostate treatment debate on August 15, 2010| Leave a Comment »
LA TIMES: Most physicians are reluctant to prescribe the drug finasteride to prevent prostate cancer in older men with elevated risk of the disease, despite evidence that the drug can reduce risk by about a quarter. READ MORE>
Prostate cancer drug Provenge finally starts earning money for its maker
Posted in Provenge, tagged advanced prostate cancer, catheter, Dendreon, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate, Provenge, Provenge treatment, WALL ST JOURNAL on August 6, 2010| Leave a Comment »
WALL ST JOURNAL: New wonder drug for treating advanced prostate cancer, Provenge, is finally making money for its manufacturer, Dendreon Corp. READ MORE>
Since the $93,000 treatment was launched at the beginning of May, doctors have written 500 prescriptions for the treatment, the company disclosed.
Former Coronation St star has prostate cancer relapse
Posted in Prostate stories, tagged advanced prostate cancer, catheter, Coronation St, Corrie TV star, Digital Spy, Eddie Yeats, Geoffrey Hughes, prostablog, prostate, prostate blog, PROSTATE CANCER, prostate cancer relapse, soap opera star on August 6, 2010| Leave a Comment »
DIGITAL SPY: Corrie St binman Eddie Yeats (real name Geoffrey Hughes) is thought to be gravely ill in hospital after he collapsed with back pains at his Isle of Wight home.
The 66-year-old (right) had supposedly beaten prostate cancer after treatment last year. READ MORE>
Prostablog 